ADHD care has recently faced intense scrutiny amid rising patient demand; tension exists between patients, clinicians and policy stakeholders. Within this landscape, ADHD treatment guidelines remain vague, leaving gaps in assessment and treatment protocols. Now more than ever, a higher standard of care that ensures positive outcomes, access, equity, and safe prescribing practices is essential. Providers are confronted with a critical challenge: What standardized elements should be included to ensure high-quality ADHD care and measurable treatment outcomes? This session brings together top clinicians and patient advocates from leading health systems, universities, and practices to establish key quality metrics in ADHD care.